Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe…

Overview of attention for article published in Health and Quality of Life Outcomes, October 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 2 news stories from 1 outlets.

Il trattamento con ossicodone a rilascio prolungato e naltrexone, consente una migliore qualità di vita, un aumento nella…

Il trattamento con ossicodone a rilascio prolungato e naltrexone, consente una migliore qualità di vita, un aumento nella…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.